E1	Eq-Comparison:T1 Operator:T42 Value:T43 Temporal-Unit:T44
E2	Condition:T2 Name:T45
E5	Eq-Comparison:T5 Operator:T47
E6	Condition:T6 Severity:T48
E7	Observation:T7 Name:T50 Numeric-Filter:E8
E8	Eq-Comparison:T8 Operator:T51 Value:T52
E9	Eq-Comparison:T9 Temporal-Period:T53
E10	Procedure:T10 Name:T54 Temporality:E9 Duration:E13
E11	Eq-Comparison:T11 Value:T55 Operator:T56
E12	Drug:T12 Name:T57 Minimum-Count:E11
E13	Eq-Comparison:T13 Operator:T58 Value:T59 Temporal-Unit:T60
E14	Condition:T14 Name:T61
E15	Drug:T15 Name:T62
E16	Eq-Comparison:T16 Temporal-Period:T63
E17	Condition:T17 Name:T64 Temporality:E16
E18	Eq-Comparison:T18 Temporal-Period:T65
E19	Drug:T19 Name:T66 Temporality:E18
E20	Other:T20 Is-Other:E3
E21	Condition:T21 Name:T67
E22	Eq-Comparison:T22 Temporal-Period:T68
E23	Condition:T23 Name:T69 Temporality:E22
E24	Condition:T24 Name:T71 Severity:T70
E25	Eq-Comparison:T25 Temporal-Period:T72
E26	Condition:T26 Name:T73 Temporality:E25
E28	Other:T28 Is-Other:E29
E29	Condition:T29 Name:T74 Temporality:E25
E30	Eq-Comparison:T30 Temporal-Period:T75
E31	Procedure:T31 Name:T76 Temporality:E30
E32	Condition:T32 Name:T77
E34	Condition:T34 Name:T78
E35	Condition:T35 Name:T79
E36	Condition:T36 Name:T80
E37	Observation:T37 Name:T81 Numeric-Filter:E38 Numeric-Filter:E4
E38	Eq-Comparison:T38 Operator:T82 Value:T4
E41	Condition:T41 Name:T88
E42	Age:T89 Numeric-Filter:E1
E3	Indication:T3 Indication-For:E19
E4	Eq-Comparison:T90 Operator:T91 Value:T83 Unit:T84 Per:T85
T1	Eq-Comparison 34 53	older than 18 years
T2	Condition 85 105	rheumatoid arthritis
T5	Eq-Comparison 166 182	moderate to high
T6	Condition 183 199	disease activity
T7	Observation 201 217	DAS - 28 . score
T8	Eq-Comparison 218 234	greater than 3.2
T9	Eq-Comparison 250 258	received
T10	Procedure 263 279	standard therapy
T11	Eq-Comparison 286 297	one or more
T12	Drug 311 317	DMARDs
T13	Eq-Comparison 323 344	at least three months
T14	Condition 377 393	hypersensitivity
T15	Drug 397 406	metformin
T16	Eq-Comparison 433 438	prior
T17	Condition 454 471	diabetes mellitus
T18	Eq-Comparison 487 494	receive
T19	Drug 495 504	metformin
T20	Other 513 518	other
T21	Condition 551 575	congestive heart failure
T22	Eq-Comparison 598 605	history
T23	Condition 609 630	myocardial infarction
T24	Condition 658 664	anemia
T25	Eq-Comparison 685 691	active
T26	Condition 692 702	infections
T28	Other 706 711	other
T29	Condition 712 733	inflammatory diseases
T30	Eq-Comparison 749 758	receiving
T31	Procedure 759 777	biological therapy
T32	Condition 784 793	Pregnancy
T34	Condition 797 806	lactation
T35	Condition 827 851	impaired liver functions
T36	Condition 872 897	impaired kidney functions
T37	Observation 899 930	serum creatinine concentrations
T38	Eq-Comparison 931 935	≥1.5
T41	Condition 1006 1018	malignancies
T42	Eq-Operator 34 44	older than
T43	Eq-Value 45 47	18
T44	Eq-Temporal-Unit 48 53	years
T45	Condition-Name 85 105	rheumatoid arthritis
T46	Severity 166 174	moderate
T47	Eq-Operator 175 177	to
T48	Severity 178 182	high
T50	Observation-Name 201 217	DAS - 28 . score
T51	Eq-Operator 218 230	greater than
T52	Eq-Value 231 234	3.2
T53	Eq-Temporal-Period 250 258	received
T54	Procedure-Name 263 279	standard therapy
T55	Eq-Value 286 289	one
T56	Eq-Operator 290 297	or more
T57	Drug-Name 311 317	DMARDs
T58	Eq-Operator 323 331	at least
T59	Eq-Value 332 337	three
T60	Eq-Temporal-Unit 338 344	months
T61	Condition-Name 377 393	hypersensitivity
T62	Drug-Name 397 406	metformin
T63	Eq-Temporal-Period 433 438	prior
T64	Condition-Name 454 471	diabetes mellitus
T65	Eq-Temporal-Period 487 494	receive
T66	Drug-Name 495 504	metformin
T67	Condition-Name 551 575	congestive heart failure
T68	Eq-Temporal-Period 598 605	history
T69	Condition-Name 609 630	myocardial infarction
T70	Severity 651 657	severe
T71	Condition-Name 658 664	anemia
T72	Eq-Temporal-Period 685 691	active
T73	Condition-Name 692 702	infections
T74	Condition-Name 712 733	inflammatory diseases
T75	Eq-Temporal-Period 749 758	receiving
T76	Procedure-Name 759 777	biological therapy
T77	Condition-Name 784 793	Pregnancy
T78	Condition-Name 797 806	lactation
T79	Condition-Name 827 851	impaired liver functions
T80	Condition-Name 872 897	impaired kidney functions
T81	Observation-Name 899 930	serum creatinine concentrations
T82	Eq-Operator 931 932	≥
T83	Eq-Value 941 944	1.4
T84	Eq-Unit 945 947	mg
T85	Eq-Unit 948 950	dL
T86	Life-Stage-And-Gender 954 959	males
T87	Life-Stage-And-Gender 964 971	females
T88	Condition-Name 1006 1018	malignancies
T89	Age 34 39	older
T3	Indication 519 530	indications
T4	Eq-Value 932 935	1.5
T90	Eq-Comparison 940 950	≥1.4 mg/dL
T91	Eq-Operator 940 941	≥
A1	Eq-Operator-Value T42 GT
A2	Eq-Temporal-Unit-Value T44 year
A3	Severity-Value T46 moderate
A4	Eq-Operator-Value T47 BETWEEN
A7	Eq-Operator-Value T51 GT
A8	Eq-Temporal-Period-Value T53 past
A9	Eq-Operator-Value T56 GTEQ
A10	Eq-Operator-Value T58 GTEQ
A11	Eq-Temporal-Unit-Value T60 month
A12	Eq-Temporal-Period-Value T63 past
A13	Eq-Temporal-Period-Value T65 present
A14	Eq-Temporal-Period-Value T68 past
A15	Severity-Value T70 severe
A16	Eq-Temporal-Period-Value T72 present
A17	Eq-Temporal-Period-Value T75 present
A18	Observation-Type-Value E37 lab
A19	Eq-Operator-Value T82 GTEQ
A20	Life-Stage-And-Gender-Type T86 male
A21	Life-Stage-And-Gender-Type T87 female
A22	Observation-Type-Value E7 clinical-score
A6	Severity-Value T48 severe
A5	Eq-Operator-Value T91 GTEQ
R1	Equivalent-To Arg1:E7 Arg2:E6
R2	Equivalent-To Arg1:E12 Arg2:E10
R3	Caused-By Arg1:E14 Arg2:E15
R4	If-Then Arg1:T86 Arg2:E38
R5	If-Then Arg1:T87 Arg2:E4
R6	Equivalent-To Arg1:E37 Arg2:E36
R7	Or Arg1:E26 Arg2:E29
R8	Or Arg1:E32 Arg2:E34
R9	Or Arg1:T86 Arg2:T87
R10	Or Arg1:E38 Arg2:E4
